NAM works to change lives by sharing information about HIV and AIDS. We believe independent, clear and accurate information is vital in the fight against HIV and AIDS. More about us >

EASL 2018: Hepatitis C treatment

An eight-week course of sofosbuvir/velpatasvir (Epclusa) cured almost all people with hepatitis C genotype 3 without cirrhosis who were also receiving opioid substitution therapy.

The conference also heard about a new and affordable hepatitis C combination that cured 97% of people in a study in Malaysia.

EASL 2018: Hepatitis C treatment

An eight-week course of sofosbuvir/velpatasvir (Epclusa) cured almost all people with hepatitis C genotype 3 without cirrhosis who were also receiving opioid substitution therapy.

The conference also heard about a new and affordable hepatitis C combination that cured 97% of people in a study in Malaysia.

Conference news: EASL 2018

The International Liver Congress 2018, the annual meeting of the European Association for the Study of the Liver (EASL), was held in Paris, France from 11 to 15 April 2018.

Jobs at NAM

NAM is looking for a Corporate Fundraising Manager to join the team.

The role is part time and based in our London office.

Applications close at 10am on Monday 14 May.

New edition: HIV & hepatitis

A new edition of our booklet HIV & hepatitis is available online and in print through our patient information scheme.

The booklet is for people living with HIV who want to know more about hepatitis A, B and C. The information in the booklet can help you to avoid getting these viruses or to treat and manage the viruses if you have them.

Conference news: CROI 2018

The annual Conference on Retroviruses and Opportunistic Infections (CROI) took place in Boston, USA, from 4 to 7 March 2018.

We reported on key research presented at the conference, published news online and sent out four conference news summary bulletins in English, Spanish, Portuguese, Russian and Italian.

Copy of Copy of New edition: HIV, stigma & discrimination

A new edition of our booklet HIV, stigma & discrimination is now available online and in print through our patient information scheme.

The booklet explains what stigma and discrimination are, makes some suggestions for how to deal with these problems and gives information about your legal rights.

aidsmap HIV & AIDS news

More news from aidsmap

Editor's picks from other sources

More Editor's picks

E-atlas Hungary

Find news, resources and services from Hungary
Or select a country from the list below

A to Z of topics

NAM news and opinions

More
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.